Your browser doesn't support javascript.
loading
MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.
Wang, Jun; Li, Xiaojuan; Xiao, Zhaoming; Wang, Yu; Han, Yuefu; Li, Jun; Zhu, Weian; Leng, Qu; Wen, Yuehui; Wen, Xinqiao.
Afiliación
  • Wang J; Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Li X; Department of Urology, Fudan University Shanghai Cancer Center, China.
  • Xiao Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang Y; Center of Health Management, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Han Y; Department of Urology, Nanfang Hospital of Southern Medical University, Guangzhou, China.
  • Li J; Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhu W; Department of Urology, Yue Bei People's Hospital, Shaoguan, China.
  • Leng Q; Department of Urology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Wen Y; Department of Urology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Wen X; Department of Urology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
FEBS Open Bio ; 9(10): 1798-1807, 2019 10.
Article en En | MEDLINE | ID: mdl-31410981
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfofructoquinasa-2 / MicroARNs / Glucólisis Límite: Humans / Male Idioma: En Revista: FEBS Open Bio Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Fosfofructoquinasa-2 / MicroARNs / Glucólisis Límite: Humans / Male Idioma: En Revista: FEBS Open Bio Año: 2019 Tipo del documento: Article País de afiliación: China